D. E. Shaw & Co., Inc. Global Blood Therapeutics, Inc. Call Options Transaction History

D. E. Shaw & Co., Inc.

5 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q1 2021 May 17, 2021	SELL	$38.94 - $50.85 $389,400 - $508,500	-10,000 Closed	0 $0
Q2 2020 Aug 14, 2020	SELL	$48.73 - $81.82 $487,299 - $818,199	-10,000 Reduced 50.0%	10,000 $631,000
Q1 2020 May 15, 2020	SELL	$41.72 - $87.2 $421,372 - $880,720	-10,100 Reduced 33.55%	20,000 $1.02 Million
Q4 2019 Feb 14, 2020	BUY	$45.7 - $81.86 $914,000 - $1.64 Million	20,000 Added 198.02%	30,100 $2.39 Million
Q4 2018 Feb 14, 2019	BUY	$31.54 - $46.67 $318,554 - $471,367	10,100 New	10,100 $415,000

288K

Ticker GBT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 67,476,200
Market Cap $4.62B
Description
Global Blood Therapeutics, Inc., a biopharmaceutical company, engages in the discovery, development, and delivery of treatments for underserved patient communities with sickle cell disease (SCD). The company offers Oxbryta tablets, an oral, once-daily therapy for SCD. It also evaluates the safety and pharmacokinetics of single and multiple doses...

Get notified when there are updates to the investment portfolio of D. E. Shaw & Co., Inc., based on Form 13F filings with the SEC.

Stay updated on D. E. Shaw & Co., Inc. with notifications on news.